XM does not provide services to residents of the United States of America.

Ulta Beauty beats first-quarter profit estimates on steady demand for skincare and makeup



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Ulta Beauty beats first-quarter profit estimates on steady demand for skincare and makeup</title></head><body>

May 30 (Reuters) -Ulta Beauty topped market expectations for first-quarter profit on Thursday, helped by steady demand for skincare and makeup as well as easing input costs.

Shares of the company, which have fallen 22% so far this year, were up 8.4% in extended trading.

Demand for beauty and personal care products has stayed resilient in the United States despite strained discretionary budgets.

Excluding items, the beauty retailer earned $6.47 per share, beating expectations of $6.24 apiece.

With consumers looking for cheaper options for makeup and skincare, Ulta Beauty has offered targeted promotions to retain customers, while also launching its luxury line with brands such as Chanel and Dior last year to help boost demand and support margins.

Lower input costs and normalizing prices for its products has also helped support margin growth at the company.

The company's quarterly net sales rose 3.5% to $2.73 billion. Analysts expected $2.72 billion, as per LSEG data.

According to data from Placer.ai, Ulta's foot traffic gains surpassed those in the overall beauty and wellness segment in the February through April period, signaling strength in demand for affordable luxuries in a choppy macro environment.

The company lowered its annual profit and revenue forecast. Still-high rental and interest rates have raised concerns that discretionary spending could be pressured for the year.

It now sees annual adjusted earnings per share between $25.20 and $26.00, compared with its earlier expectation of $26.20 to $27.00.

Ulta forecast annual net sales between $11.5 billion to $11.6 billion, versus prior expectations of $11.7 to $11.8 billion.

As a percentage of net sales, quarterly gross profit decreased to 39.2%, compared with 40% last year.



Reporting by Juveria Tabassum and Sneha S K; Editing by Alan Barona

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.